Saktimayee M Roy Selected Research

MW01-18-150SRM

1/2017

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saktimayee M Roy Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 09/2007
3	Cognitive Dysfunction 01/2017 - 01/2013
1	Hyperhomocysteinemia 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Injection Site Reaction 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Cerebral Hemorrhage 01/2021
1	Neoplasms (Cancer) 04/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Amyloid Plaque 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Tauopathies 12/2016
1	Disease Progression 04/2015
1	Disease Susceptibility (Diathesis) 04/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2007

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	CytokinesIBA 01/2021 - 09/2007
2	Phosphotransferases (Kinase)IBA 01/2017 - 04/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	TT-301IBA 01/2021
1	SolutionsIBA 01/2021
1	Aurora KinasesIBA 04/2019
1	Protein Kinase InhibitorsIBA 04/2019
1	MW01-18-150SRMIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	CX3C Chemokine Receptor 1IBA 12/2016
1	p38 Mitogen-Activated Protein KinasesIBA 12/2016
1	tau Proteins (tau Protein)IBA 12/2016
1	Protein Kinases (Protein Kinase)IBA 04/2015
1	Protein Isoforms (Isoforms)IBA 04/2015
1	Amyloid beta-PeptidesIBA 01/2013

Therapy/Procedure

1	Therapeutics 09/2007